Cardinal Health Settles for $8.8 Million With SEC in FCPA Case

Cardinal Health Inc. has agreed to pay about $8.8 million to settle SEC claims that it didn’t have sufficient internal accounting controls in place to detect alleged Foreign Corrupt Practices Act violations. The Ohio-based pharmaceutical distributor allegedly failed to detect improper transactions made to employees of its former Chinese pharmaceutical and medical-device distribution subsidiary, Cardinal […]
Must be a Paid Member or a Free Trial Member to Access Content. Members log in here.